UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-01 | Future report Set alerts | |
| Q2 2022 | 2022-08-09 | 0.30 | 0.30 |
| Q1 2022 | 2022-04-28 | 0.59 | 0.59 |
| Q4 2021 | 2022-02-24 | 0.17 | 0.17 |
| Q3 2021 | 2021-11-03 | -0.06 | -0.06 |
| Q2 2021 | 2021-08-04 | -0.27 | -0.27 |
| Q1 2021 | 2021-05-05 | -0.54 | -0.54 |
| Q4 2020 | 2021-02-18 | -0.32 | -0.32 |
| Q3 2020 | 2020-10-29 | -0.67 | -0.67 |
| Q2 2020 | 2020-08-05 | -0.19 | -0.19 |
| 2016-05-02 | Boost Price Target | Deutsche Bank | Hold | $7.00 to $7.50 |
| 2016-05-02 | Boost Price Target | Deutsche Bank AG | Hold | $7.00 to $7.50 |
| 2016-04-30 | Reiterated Rating | Cowen and Company | Hold | |
| 2016-04-29 | Boost Price Target | Cowen and Company | Market Perform | $6.00 to $8.00 |
| 2016-03-23 | Reiterated Rating | Deutsche Bank | Hold | $6.00 to $7.00 |
| 2016-03-18 | Reiterated Rating | Nomura | Neutral | $5.00 |
| 2016-03-18 | Reiterated Rating | Nomura Holdings Inc. | Neutral | $5.00 |
| 2016-02-22 | Downgrade | BMO Capital Markets | Outperform to Market Perform | $6.00 |
| 2016-02-22 | Boost Price Target | Deutsche Bank | Hold | $4.00 to $6.00 |
| 2016-02-20 | Reiterated Rating | Cowen and Company | Hold | |
| 2016-02-19 | Reiterated Rating | Nomura | Neutral | $4.00 to $5.00 |
| 2016-02-19 | Boost Price Target | Cowen and Company | Market Perform | $4.00 to $6.00 |
| 2016-01-24 | Downgrade | Morgan Stanley | Hold | |
| 2015-11-09 | Downgrade | Nomura | Buy to Neutral | $12.00 to $4.00 |
| 2015-10-30 | Reiterated Rating | Cowen and Company | Market Perform | $7.00 to $4.00 |
| 2015-10-05 | Downgrade | Deutsche Bank | Buy to Hold | $10.00 to $7.00 |
| 2015-08-28 | Reiterated Rating | Deutsche Bank | Buy | $19.00 to $10.00 |
| 2015-08-18 | Reiterated Rating | Morgan Stanley | Underweight | |
| 2015-08-10 | Reiterated Rating | Deutsche Bank | Buy | $19.00 |
| 2015-08-08 | Reiterated Rating | Cowen and Company | Hold | |
| 2015-08-07 | Lower Price Target | Cowen and Company | Market Perform | $10.00 to $7.00 |
| 2015-07-21 | Lower Price Target | Morgan Stanley | Underweight | $41.00 to $8.00 |
| 2015-07-02 | Lower Price Target | Deutsche Bank | Buy | $25.00 to $19.00 |
| 2015-05-28 | Lower Price Target | JPMorgan Chase & Co. | Underweight | $7.00 to $5.00 |
| 2015-04-06 | Lower Price Target | Deutsche Bank | Buy | $27.00 to $25.00 |
| 2015-03-31 | Lower Price Target | JPMorgan Chase & Co. | Underweight | $14.00 to $8.00 |
| 2015-03-24 | Downgrade | Morgan Stanley | Equal Weight to Underweight | $18.00 to $12.00 |
| 2015-03-18 | Upgrade | Standpoint Research | Hold to Buy | |
| 2015-03-05 | Reiterated Rating | Deutsche Bank | Buy | $32.00 to $27.00 |
| 2015-03-05 | Downgrade | Morgan Stanley | Overweight to Equal Weight | $29.00 to $18.00 |
| 2015-03-04 | Downgrade | Bank of America | Buy to Neutral | $39.00 to $23.00 |
| 2015-03-04 | Downgrade | Bank of America Corp. | Buy to Neutral | $39.00 to $23.00 |
| 2015-02-09 | Downgrade | JPMorgan Chase & Co. | Neutral to Underweight | $20.00 to $17.50 |
| 2015-02-03 | Initiated Coverage | Nomura | Buy | $28.00 |
| 2015-01-23 | Downgrade | JPMorgan Chase & Co. | Overweight to Neutral | $24.00 to $20.00 |
| 2015-01-12 | Reiterated Rating | Deutsche Bank | Buy | $32.00 |
| 2014-11-18 | Initiated Coverage | BMO Capital Markets | Outperform | |
| 2014-09-30 | Upgrade | Bank of America | Neutral to Buy | $21.00 to $30.00 |
| 2014-09-03 | Initiated Coverage | Morgan Stanley | Buy | $30.00 |
| 2014-09-03 | Boost Price Target | CRT Capital | Buy | $23.00 to $34.00 |
| 2014-09-03 | Initiated Coverage | Deutsche Bank | Buy | $30.00 |
| 2014-09-02 | Upgrade | Morgan Stanley | Equal Weight to Overweight | $33.00 |
| 2014-08-04 | Boost Price Target | CRT Capital | Buy | $18.50 to $23.00 |
| 2014-07-31 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $15.00 to $24.00 |
| 2014-07-31 | Boost Price Target | Cowen and Company | $13.00 to $19.00 | |
| 2014-07-07 | Upgrade | Goldman Sachs | Sell to Neutral | $8.00 to $15.50 |
| 2014-07-07 | Upgrade | Goldman Sachs Group Inc. | Sell to Neutral | $8.00 to $15.50 |
| 2014-06-02 | Upgrade | Bank of America | Underperform to Neutral | $9.00 to $14.00 |
| 2014-05-07 | Initiated Coverage | Furey Research Partners | Buy | $18.50 |
| 2014-05-07 | Initiated Coverage | CRT Capital | Buy | |
| 2014-03-06 | Upgrade | JPMorgan Chase & Co. | Equal Weight to Positive | |
| 2014-02-21 | Boost Price Target | Barclays | Overweight | $11.00 to $13.00 |
| 2014-02-05 | Downgrade | Cowen | Outperform to Market Perform | $10 to $9 |
| 2014-02-05 | Downgrade | Cowen and Company | Outperform to Market Perform | $10.00 to $9.00 |
| 2014-01-21 | Upgrade | JPMorgan Chase & Co. | Underweight to Overweight | $6.00 to $13.00 |
| 2013-12-17 | Downgrade | JPMorgan Chase & Co. | Neutral to Underweight | $9.00 to $6.00 |
| 2013-10-08 | Reiterated | Cowen | Outperform | $13 to $10 |
| 2013-10-08 | Reiterated Rating | Goldman Sachs | Sell | |
| 2013-10-08 | Lower Price Target | Cowen and Company | Outperform | $13.00 to $10.00 |
| 2013-10-07 | Lower Price Target | Morgan Stanley | Equal Weight | $10.00 to $9.00 |
| 2013-04-30 | Upgrade | Cowen | Hold to Buy | $13 |
| 2013-04-26 | Reiterated | Barclays | Overweight | $11 to $9 |
| 2011-11-23 | Initiated | Stifel Nicolaus | Hold | |
| 2010-11-08 | Downgrade | Davenport | Buy to Neutral | |
| 2009-08-07 | Downgrade | Standpoint Research | Buy to Hold | |
| 2009-05-06 | Initiated | Standpoint Research | Buy | |
| 2009-02-04 | Downgrade | BMO Capital Markets | Outperform to Market Perform | |
| 2009-01-28 | Reiterated | Friedman Billings | Mkt Perform | $8 to $6 |
| 2008-12-19 | Downgrade | Friedman Billings | Outperform to Mkt Perform | $18 to $8 |
| 2008-11-19 | Downgrade | JP Morgan | Overweight to Neutral | |
| 2008-11-11 | Reiterated | Friedman Billings | Outperform | $35 to $18 |
| 2008-10-20 | Reiterated | Credit Suisse | Outperform | $77 to $25 |
| 2016-05-02 | Boost Price Target | Deutsche Bank | Hold | $7.00 to $7.50 |
| 2016-05-02 | Boost Price Target | Deutsche Bank AG | Hold | $7.00 to $7.50 |
| 2016-04-30 | Reiterated Rating | Cowen and Company | Hold | |
| 2016-04-29 | Boost Price Target | Cowen and Company | Market Perform | $6.00 to $8.00 |
| 2016-03-23 | Reiterated Rating | Deutsche Bank | Hold | $6.00 to $7.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CENX 146 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 9.48M |
| STATE STREET CORP | 8.27M |
| Vanguard Group, Inc | 6.43M |
| BlackRock Fund Advisors | 4.09M |
| DIMENSIONAL FUND ADVISORS LP | 3.14M |
| Fisher Asset Management, LLC | 2.52M |
| BlackRock Institutional Trust Company, N.A. | 1.47M |
| CITADEL ADVISORS LLC | 1.47M |
| MORGAN STANLEY | 1.34M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.98M |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.86M |
| Mirae Asset Global Investments Co., Ltd. | 0.72M |
| TWO SIGMA INVESTMENTS LLC | 0.69M |
| RENAISSANCE TECHNOLOGIES LLC | 0.67M |
| SCHWAB CHARLES INVESTMENT MANAGEMENT INC | 0.64M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Glencore AG | 11.35% (10082856) | CENX / |
| BLESS MICHAEL A Exec. VP and CFO | 0.43% (379873) | CENX / SSD / |
| Kruger Logan W CEO and President | 0.24% (211148) | CENX / CNL / |
| Kjos David VP Maj Proj. Tech. & Sustain | 0.17% (153222) | CENX / |
| Gary Jesse E EVP, Gen. Counsel & Secretary | 0.13% (114094) | CENX / |
| Hale Wayne EVP and COO | 0.13% (113564) | CENX / NOR / |
| Hoerner John E. VP of N. American Operations | 0.12% (107999) | CENX / |
| Berntzen Jarl | 0.11% (97908) | CENX / |
| OBRIEN JOHN P | 0.07% (64259) | CENX / |
| Wilkinson Terence | 0.07% (61980) | CENX / |
| Dillon Ricky T EVP & Chief Financial Officer | 0.06% (52253) | ATU / CENX / |
| Lair Michelle VP & Treasurer | 0.06% (51004) | CENX / |
| JONES PETER C | 0.05% (46852) | CENX / |
| SCHNEIDER STEVE Sr. VP & Chief Acct. Officer | 0.05% (43590) | CENX / |
| Leatherberry William J EVP, Gen. Counsel & Secretary | 0.05% (43109) | CENX / NMIH / |
| GLASSER ERROL | 0.04% (35100) | CENX / |
| Reed Jerry E VP, Commercial Mgmt & Bus. Dev | 0.04% (34208) | CENX / |
| Michelmore Andrew G | 0.03% (27429) | CENX / |
| THOMPSON JACK EDWARD | 0.03% (25112) | CENX / MCP / TDW / |
| FONTAINE JOHN C | 0.02% (21427) | CENX / |
| Heyroth Stephen K. Chief Accounting Officer | 0.02% (20567) | CENX / |
| Hoffman Robert F Principal Accounting Officer | 0.01% (9192) | CENX / |
UM